GSE201504
A promising clinical treatment for EGFRI-induced rash by targeting the early pathological alteration revealed by transcriptome analysis
In order to investigate the early pathological alteration of EGFRI-induced rash, we treated rat with vehicle or afatinib for 3 days. We then performed gene expression profiling analysis using data obtained from RNA-Seq of 3 different rat skins in each group Overall design: Comparative gene expression profiling analysis of RNA-seq data for control rat skins (vehicle treated) and afatinib-treated rat skins, in triplicate.